Silhouette

Ake P Elhammer

Aureogen Biosciences, Inc.

Employers

Affiliated Awards

Award Title Agency Phase Award amount Start Date End Date
Novel Antifungals by Engineering the AbA NRPS gene
Aureogen Biosciences, Inc.
Principal Investigator
HHS 2 $241K 02/01/12 01/31/13
Novel Antifungals by Engineering the AbA NRPS gene
Aureogen Biosciences, Inc.
Principal Investigator
HHS 2 $241K 02/01/11 01/31/12
Generation of novel HCV drugs through engineereing of the cssA gene
Aureogen Biosciences, Inc.
Principal Investigator
HHS 1 $300K 04/01/09 03/31/11
Generation of novel drugs against drug resistant bacteria through engineering of
Aureogen Biosciences, Inc.
Principal Investigator
HHS 1 $287K 06/13/08 05/31/10
Novel Antifungals by Engineering the AbA NRPS gene
Aureogen Biosciences, Inc.
Principal Investigator
HHS 2 $683K 06/01/08 05/31/10
Generation of novel HCV drugs through engineereing of the cssA gene
Aureogen Biosciences, Inc.
Principal Investigator
HHS 1 $300K 04/01/08 03/31/09
A Bacitracin derivative for systemic use
Aureogen Biosciences, Inc.
Principal Investigator
HHS 1 $381K 07/01/07 06/30/09
Novel Antifungals by Engineering the AbA NRPS gene
Aureogen Biosciences, Inc.
Principal Investigator
HHS 2 $658K 06/01/07 05/31/08
Novel Antifungals by Engineering the AbA NRPS gene
Aureogen Biosciences, Inc.
Principal Investigator
HHS 2 $638K 06/01/06 05/31/07
Novel Antifungals by Engineering the AbA NRPS gene
Aureogen Biosciences, Inc.
Principal Investigator
HHS 1 $163K 09/30/04 09/30/05